NRX Pharmaceuticals, Inc. (NRXP) Financials

NRXP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 13.1 million 19.3 million
2023-06-30 19.8 million 22.6 million
2023-03-31 21.8 million 22.1 million
2022-12-31 25.8 million 18.4 million

NRXP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.6 million 351000
2023-06-30 -7.8 million 544000
2023-03-31 -6.1 million 695000
2022-12-31 -8.3 million 766000

NRXP Net Income

No data available :(

NRXP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 8.9 million - -
2023-06-30 15.0 million - -
2023-03-31 16.5 million - -
2022-12-31 20.1 million - -

NRXP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 81.9 million
2023-06-30 73.2 million
2023-03-31 67.5 million
2022-12-31 65.8 million

NRXP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2000 3.3 million 2.5 million -
2023-06-30 2000 3.9 million 4.1 million -
2023-03-31 4000 3.7 million 5.8 million -
2022-12-31 1000 4.5 million 5.4 million -

NRXP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 2000
2023-06-30 - 1000
2023-03-31 - 1000
2022-12-31 - 1000

NRXP

Price: $3.06

52 week price:
2.06
12.00

Earnings Per Share: -4.00 USD

P/E Ratio: -0.96

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 246900

Market Capitalization: 49.0 million

Links: